EQS-News: Dermapharm Holding SE
/ Key word(s): Annual Results/Annual Report
Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance
28.03.2025 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.Read More
You might also be interested in reading IG Group Set to Join FTSE 100 as easyJet May Face Removal in March Review.